Large serpiginous thrombus straddling the patent foramen ovale and traversing through mitral and tricuspid valves into both ventricles: a therapeutic dilemma of impending paradoxical embolism and recurrent pulmonary embolism. ABSTRACT A 51-year-old male with history of resected renal cell carcinoma and prior pulmonary embolism presented with tachypnea, tachycardia and progressive dyspnea on exertion. Chest computed tomography revealed bilateral acute pulmonary embolism. Transthoracic echocardiogram showed severe pulmonary hypertension with severe cor-pulmonale and presence of a large worm-like thrombus extending across the foramen ovale, entering both ventricles through the mitral and tricuspid valves. The risks of anticoagulation, pharmacologic thrombolysis, and surgical thrombectomy, in a hemodynamically stable patient, posed a significant therapeutic dilemma. Ultimately, a collective decision was made to start anticoagulation, without incident. At 1 month follow up, complete resolution of the intracardiac thrombus, pulmonary hypertension, and cor-pulmonale were observed with full clinical recovery of the patient.
. Limited visualization of the cardiac chambers due to the non-electrocardiographic gated prior chest CT scan (per PE protocol), precluded assessment of intracardiac thrombus. Although the patient had remote history of renal cell carcinoma with partial right nephrectomy, no evidence of recurrence on chest, abdominal and pelvic CT was identified. A lower extremity venous Doppler study demonstrated a focal, acute, right soleal deep venous thrombosis (DVT) (Figure 4 ).
Management
In hemodynamically stable patients at risk for recurrent fatal pulmonary and systemic embolism, the management strategy is not clearly defined. This is due to the significant risks associated with thrombolytics and surgical thrombectomy compared to anticoagulation. In our patient there was a clear potential for arterial and pulmonary embolization due to the left and right atrial highly mobile thrombus. The significant pulmonary hypertension and severe right ventricular dysfunction raised concerns of the patient's ability to tolerate repeat pulmonary embolism, risk of thrombolytics, or difficult weaning from cardiopulmonary bypass with thrombectomy. Similarly, no literature or guidelines are available on different anticoagulation strategies other than heparin followed by warfarin in patients with impending paradoxical embolism. After consultative consensus, conservative therapy with heparin 1150 units/hr and warfarin 5 mg po once a day was instituted. Patient remained hemodynamically stable and was discharged home after 5 days with therapeutic INR.
Follow up
At one month, follow up TTE revealed complete resolution of biatrial thrombus with normalization of RV size and function and pulmonary artery pressures. A saline contrast study confirmed the presence of a patent foramen ovale with right to left shunt during Valsalva maneuver ( Figure 5 A-D). To date, patient remains clinically stable on warfarin therapy.
Etiology & demographics
Paradoxical embolism [1] is characterized by a venous thrombus entering the systemic arterial circulation through a right to left shunt. The shunt can be intra-cardiac: i.e. patent foramen ovale [PFO] , atrial septal defect [ASD] , ventricular septal defect [VSD] ; or extra-cardiac: i.e. pulmonary arteriovenous (AV) fistula. The venous thrombus can originate in lower extremity veins, pelvic veins, in the atria during atrial fibrillation or flutter, in the atria in patients with central venous catheters, in an atrial septal aneurysm or from the edges of a PFO. Impending paradoxical embolism (IPE) is characterized by a thrombus trapped and in transit through a right to left shunt, i.e. a thrombus seen in a PFO but without clinical evidence of systemic arterial emboli.
Conheim [2] reported the first suspected case of paradoxical embolism in 1877. The first case of impending paradoxical embolism was published in 1985 initially documented by transesophageal echocardiography (TEE) and confirmed at surgery [3] . With improvements in both invasive and non-invasive imaging techniques, the diagnosis in living patients has been facilitated [4] [5] [6] Loscalzo et al [7] presented a review of 30 patients with paradoxical embolism. 66% and 43% of their patients respectively had evidence of PE and DVT. DVT was attributed to post-operative state, obesity, myocardial infarction and congestive heart failure. Systemic arterial embolism was peripheral vs. cerebral in 49% vs. 37% of the patients. PFO was found to be the etiology for right to left shunt in 72% of the patients, while in 10%, 10% and 3% had ASD, pulmonary AV fistulas and VSDs respectively. Reports have been published of PFO with a straddling thrombus, some with and some without evidence of systemic embolism. Fauveau E eta l [8] published a nice review of 93 such cases and added 4 new cases to this report. The mean age of these patients was 58 ± 15 years and 42% were male. Impending embolism was identified in 56% while 44% indeed had paradoxical embolism.
We searched PubMed, since the publication of this comprehensive review of, from 2009 to 2013 and we found few more cases. A brief review of these cases of 'impending paradoxical embolus' through thrombus bestriding the PFO is presented in Table 1[ [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Of note, all except 2 had presence of DVT, 2 patients had confirmation of cerebral emboli and one each had renal and coronary emboli.
Clinical & imaging findings
In patients presenting with DVT or PE in the presence of right to left shunt, it is important to have a high index of suspicion for silent left-sided emboli. Elevated right-sided pressures or pulmonary hypertension (PH) in the above setting greatly increases the risk of paradoxical systemic emboli. PH is commonly seen in patients with chronic obstructive airway disease (COPD) and in patients with obstructive sleep apnea (OSA). An unusual case of elevated right-sided pressure from tricuspid stenosis due to thrombus obstructing the tricuspid valve has also been reported [21] . Temporary increase in rightsided pressures with cough, vomiting, defecation or shivering in a patient with straddling thrombus in the PFO, increase the likelihood of dislodgement.
Non-invasive cardiovascular imaging helps identify the presence of PFO, intra-cardiac thrombus, PE, DVT as well as, presence of PH. TTE with Doppler allows us to estimate pulmonary arterial pressures (PAP). In the absence of pulmonary flow obstruction, the tricuspid regurgitation (TR) peak velocity is linearly correlated with increased in systolic PAP (SPAP) against the gold standard, invasive cardiac catheterization [22] . Similarly, peak diastolic and end-diastolic velocities of pulmonary regurgitation (PR) correlate with mean PAP (MPAP) and pulmonary arterial end-diastolic pressure (PA-EDP) respectively [22] . Pulmonary vascular resistance (PVR) is estimated by dividing TR peak velocity by the time velocity integral of RV outflow tract [22] . According to European Society of Cardiology guidelines, PH is likely present in the presence of TR velocity >3.4 m/sec and SPAP >50 mm Hg with and without additional signs of PH [23] . The other signs of PH include: enlarged right sided cardiac chambers, increased interventricular septal thickness, reduced DISCUSSION global RV systolic function and flattening of the interventricular septum during late systole and early diastole, but can persists throughout diastole when volume overload from secondary moderate or worse tricuspid and pulmonary regurgitation are present [24] . On contrast-enhanced chest CT, the signs of PH include: Enlargement of main pulmonary artery, RV hypertrophy and dilatation, RV dysfunction (identified if gated cardiac scan is performed) and bronchial artery dilatation. Cardiac CT and magnetic resonance imaging (CMR) also help evaluate for presence of anomalous pulmonary venous return, intracardiac shunt or pulmonary AV malformation [25] . CT also helps to diagnose pulmonary causes of pulmonary hypertension.
[26] [ Figure 6 ]. Doppler ultrasonography of peripheral veins helps identify presence of venous thrombus and doppler arterial examination can help localize arterial embolism.
Treatment & prognosis
General consensus is lacking regarding optimal treatment of impending paradoxical embolism, particularly in a hemodynamically stable patient [27] . In patients with acute pulmonary embolism with severe hypoxia, significant right heart dysfunction, or hemodynamic instability, thrombolytics, extracorporeal membrane oxygenation (ECMO), or surgical thrombectomy [5] can be considered. Similarly, thrombolytics or thrombectomy can be entertained when there is evidence of peripheral arterial embolism.
In stable patients with impending paradoxical embolism, however, treatment options include: IV and oral anticoagulation vs. anticoagulation with intravenous (IV) thrombolytics [28] [29] [30] [31] vs. thrombectomy/embolectomy [32] [33] [34] [35] with or without PFO/ASD closure (surgical or percutaneous). Although the risk exists for thrombus fragmentation and embolization when IV thrombolytics are employed, the true incidence of this complication is unknown. In Fauveau's [8] case series, inclusive of patients with impending systemic embolism, 55 patients were treated surgically, 21 with heparin, and 11 with thrombolysis. Their mortality rates were 13%, 14%, and 36% respectively. However, a bias was noted towards treatment with heparin in older patients and in patients with stroke, while patients who received thrombolytics were more likely to have hemodynamic compromise. Bonvinie et al [36] , reported the mortality rate of thrombolytic treatment between 16% and 22%.
In the recent systematic review of 154 patients by Myers et al [37] , the 30-day mortality rate of impending paradoxical embolism was found to be 18.4%. On multivariate analysis, none of the treatment choices (surgery, thrombolytics or anticoagulation) had a significant survival advantage. Surgically treated patients were found to have a nonsignificant trend towards decreased mortality (OR, 0.65, p=0.65) while patients treated with thrombolytics had a nonsignificant trend towards increased mortality (OR, 1.62, p =0.47), but had fewer systemic embolic events (OR 0.13, p=0.02) . The combined endpoint of systemic emboli and death was significantly lower with surgery (OR, 0.26, p=0.001 ). It appears that when immediate surgery is not available to a hemodynamically unstable patient, thrombolysis may be a viable option [38] .
In our review of recent 13 cases (Table 1) of impending systemic embolism, four of which eventually had systemic emboli, 4 received thrombolytics, 6 underwent surgical thrombectomy, and 3 received anticoagulation.
Differential Diagnoses
The differential diagnosis of impending systemic embolism in patients with DVT or PE includes cardiomyopathy with right and left sided mural thrombi, atrial fibrillation with intracardiac thrombi, right ventricular myocardial infarction with a right ventricular thrombus, central venous catheter with associated atrial thrombi, left or rightsided non-infective (Libman-Sacks or thrombotic vegetations) or infective endocarditis, atrial myxoma, or papillary fibroelastoma. In the presence of systemic embolism in a patient with venous thrombosis, mechanism of paradoxical embolism, via intra-cardiac or intrapulmonary shunting needs to be determined. This can be accomplished by either noninvasive (contrast echocardiography, CT or MRI) or invasive (cardiac catheterization) means.
Contrast agents and provocative maneuvers i.e. Valsalva or cough can improve the diagnostic yield for diagnosing shunt with both non-invasive imaging modalities (Contrast 2D with or without 3 D transthoracic or trans-esophageal echocardiography or contrast cardiac CT or cardiac magnetic resonance imaging with provocative maneuvers) or invasive imaging modalities (e.g. invasive right heart catheterization with oxymetries). [39, 40] .
Future studies required in this area:
To our knowledge, this is the first case of large pulmonary emboli complicated by severe cor-pulmonale with a large thrombus straddling the PFO and extending into both ventricles in addition to a saddle pulmonary emboli. The success of anticoagulation alone in our case also supports a conservative approach to similar patients. However, the only definitive way to establish the ideal therapy is to perform an appropriately stratified, randomized controlled trial on patients with IPE. Such a trial would obviously have to be a multicenter study, due to the small incidence of IPE.
Acute pulmonary embolism with impending paradoxical systemic embolism is an entity that may be recognized more frequently due to the availability of echocardiography in most of clinical centers. Despite numerous case reports, optimal management of impending paradoxical emboli is unknown. Anticoagulation therapy might be an effective and safe therapeutic alternative in patients with impending paradoxical systemic embolism. 
Risk factors
Postoperative state, obesity, hypercoagulable conditions including malignancy, myocardial infarction, prolonged immobilization, congestive heart failure.
Treatment
Anticoagulation with heparin or Bivalirudin, intravenous thrombolytics, surgical thrombectomy and embolectomy along with surgical closure of right of left shunt e.g. patent foramen ovale or atrial septal defect) followed by oral anticoagulants Prognosis Depends on the presence of hemodynamic collapse. 18% mortality was noted by Myers et al [2] . Amongst survivors the following can happen: systemic embolism, cardiac arrest, cardiogenic shock, right heart failure, acute myocardial ischemia or infarct, seizures, stroke and peripheral vascular ischemia.
Findings on imaging
-TTE or TEE with saline contrast study with and without provocative maneuvers (straining, cough, Valsalva) revealing presence of PFO, ASD or VSD with right to left or bidirectional shunt. A thrombus will be visualized straddling the fossa ovale extending from the right to left atrium. Delayed (after 4 cardiac cycles) presence of bubbles on the left side may indicate presence of pulmonary AV connection.
-CT scan of chest with contrast, showing presence of right to left shunt, presence of PFO, ASD or VSD and presence of thrombus in the cardiac chambers and through the intracardiac shunt. CT scan will also show presence of pulmonary embolism.
-CMR (cardiac magnetic resonance) with and without gadolinium, showing presence of right to left shunt, presence of PFO, ASD or VSD and presence of thrombus in the cardiac chambers and through the intracardiac shunt.
-Arterial and venous Doppler ultrasonography of the extremities will reveal presence of thrombus.
-VQ scan showing presence of segmental or subsegmental pulmonary embolism. -Presence of right to left shunt, presence of PFO, ASD or VSD and presence of thrombus in the cardiac chambers and through the intracardiac shunt.
-CT scan will also show presence of pulmonary embolism.
-Presence of right to left shunt, presence of PFO, ASD or VSD and presence of thrombus in the cardiac chambers and through the intracardiac shunt. Large serpiginous thrombus straddling the patent foramen ovale and traversing through mitral and tricuspid valves into both ventricles: a therapeutic dilemma of impending paradoxical embolism and recurrent pulmonary embolism.
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